PHASE IB STUDY OF CC‐122 IN COMBINATION WITH OBINUTUZUMAB (GA101): RELAPSED OR REFRACTORY (R/R) PATIENTS WITH B‐CELL NON‐HODGKIN LYMPHOMAS (NHL). (June 2017)